SG11201507578PA - Toxoid, compositions and related methods - Google Patents

Toxoid, compositions and related methods

Info

Publication number
SG11201507578PA
SG11201507578PA SG11201507578PA SG11201507578PA SG11201507578PA SG 11201507578P A SG11201507578P A SG 11201507578PA SG 11201507578P A SG11201507578P A SG 11201507578PA SG 11201507578P A SG11201507578P A SG 11201507578PA SG 11201507578P A SG11201507578P A SG 11201507578PA
Authority
SG
Singapore
Prior art keywords
toxoid
compositions
related methods
methods
Prior art date
Application number
SG11201507578PA
Other languages
English (en)
Inventor
Mark Shieh
Mike Soika
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50489432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201507578P(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of SG11201507578PA publication Critical patent/SG11201507578PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dermatology (AREA)
SG11201507578PA 2013-03-15 2014-03-14 Toxoid, compositions and related methods SG11201507578PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793376P 2013-03-15 2013-03-15
PCT/US2014/029070 WO2014144594A1 (en) 2013-03-15 2014-03-14 Toxoid, compositions and related methods

Publications (1)

Publication Number Publication Date
SG11201507578PA true SG11201507578PA (en) 2015-10-29

Family

ID=50489432

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507578PA SG11201507578PA (en) 2013-03-15 2014-03-14 Toxoid, compositions and related methods

Country Status (13)

Country Link
US (1) US20160030542A1 (enExample)
EP (1) EP2970400A1 (enExample)
JP (1) JP2016519671A (enExample)
KR (1) KR20150133771A (enExample)
CN (1) CN105308066A (enExample)
AR (1) AR095668A1 (enExample)
AU (2) AU2014228983B2 (enExample)
BR (1) BR112015023469A8 (enExample)
CA (1) CA2907156A1 (enExample)
HK (1) HK1213917A1 (enExample)
SG (1) SG11201507578PA (enExample)
TW (1) TW201518316A (enExample)
WO (1) WO2014144594A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201510166YA (en) 2013-06-14 2016-01-28 Sanofi Pasteur Inc Compositions and methods of immunizing against c. difficile
CN108003224A (zh) * 2017-12-20 2018-05-08 天康生物股份有限公司 一种多杀性巴氏杆菌毒素蛋白的纯化方法
WO2023232901A1 (en) 2022-06-01 2023-12-07 Valneva Austria Gmbh Clostridium difficile vaccine
WO2024160901A1 (en) 2023-02-02 2024-08-08 Glaxosmithkline Biologicals Sa Immunogenic composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071759A (en) * 1986-05-30 1991-12-10 The United States Of America As Represented By The Secretary Of The Army Hybridoma cell lines and monoclonal antibodies to clostridum difficile toxins A and B
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
EP2182922A4 (en) 2007-07-26 2010-07-28 Sanofi Pasteur Ltd ANTIGEN-ADJUVANS COMPOSITIONS AND METHOD
JP5503543B2 (ja) * 2007-09-14 2014-05-28 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー クロストリジウム・ディフィシレトキソイドａおよびｂを含有する薬学的組成物
GB0921288D0 (en) * 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection

Also Published As

Publication number Publication date
CA2907156A1 (en) 2014-09-18
WO2014144594A1 (en) 2014-09-18
HK1213917A1 (zh) 2016-07-15
BR112015023469A2 (pt) 2017-07-18
AR095668A1 (es) 2015-11-04
AU2014228983B2 (en) 2018-04-05
AU2018204879A1 (en) 2018-07-26
EP2970400A1 (en) 2016-01-20
AU2014228983A1 (en) 2015-10-08
TW201518316A (zh) 2015-05-16
WO2014144594A8 (en) 2014-11-13
JP2016519671A (ja) 2016-07-07
BR112015023469A8 (pt) 2019-12-03
US20160030542A1 (en) 2016-02-04
KR20150133771A (ko) 2015-11-30
CN105308066A (zh) 2016-02-03

Similar Documents

Publication Publication Date Title
IL273205A (en) Preparations and methods
GB2527241B (en) Compositions and methods
IL286759A (en) Therapeutic methods and preparations
GB201308072D0 (en) Compositions and methods
SMT201900635T1 (it) Composizioni e metodi di attivazione della segnalazione dipendente dallo "stimolatore di geni interferone"
EP2951283A4 (en) Compositions and methods
ZA201603237B (en) Pesticidal compositions and related methods
ZA201603227B (en) Pesticidal compositions and related methods
IL245035A0 (en) Pesticides and related methods
ZA201603229B (en) Pesticidal compositions and related methods
SG11201507608PA (en) Toxoid, compositions and related methods
GB201305813D0 (en) Compositions and methods
PL2988764T3 (pl) Kompozycje przeciwłupieżowe i sposoby ich zastosowania
IL276126B (en) Preparations containing l-4-chloroquinonerine and their uses
IL245034A0 (en) Pesticides and related methods
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
ZA201603241B (en) Pesticidal compositions and related methods
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
HUE037525T2 (hu) Kis sejtmagvacska RNS (SNORNA), készítmények és alkalmazások
SG11201604904XA (en) Detergent and rinse-aid compositions and methods
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
SG11201507578PA (en) Toxoid, compositions and related methods
PT2980096T (pt) Métodos de preparação de 2,3,5 tri-hidroxi-androst-6-ona e utilização do mesmo
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods